Timothy P. Clackson

This profile gathers the share dealings of Timothy P. Clackson across 4 companies, led by Elevation Oncology, Inc., Forma Therapeutics Holdings, Inc. and Ariad Pharmaceuticals Inc. We count 10 filings; the first trade dates from 1 February 2016 and the latest from 23 July 2025.

On the open market, the record shows 2 purchases worth €39k and 1 sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 1 option exercise.

The record was last updated on 24 July 2025 with a transaction (€14k) in Elevation Oncology, Inc. The last purchase on record was published on 14 November 2022, which is 1,434 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.